RNAO, however, will only support this increased scope of practice if 1)cost-effectiveness to tax payers is neutral and patients will not need to pay out of pocket, 2) delegation to an unregulated care provider is removed, and 3) mitigation strategies are required to protect the very sick and immunocompromised individuals for treatment in public places, such as grocery stores and other public place